MEDIPOST’s PNEUMOSTEM Receives Fast Track Designation from the US FDA2019/08/22STEM CELL THERAPEUTIC
MEDIPOST Registers European Patent for the Mesenchymal Stem Cell Culture Method2019/07/24STEM CELL THERAPEUTIC
MEDIPOST Registers the Canadian Patent for a Mesenchymal Stem Cell Culture Method2019/06/26STEM CELL THERAPEUTIC
MEDIPOST’s Injectable Cell Therapeutic for Knee Osteoarthritis Receives Phase 1 Clinical Trial Approval2019/05/31STEM CELL THERAPEUTIC
MEDIPOST, announces a domestic and international clinical experience at the ISCT annual meeting2019/05/30STEM CELL THERAPEUTIC
Results from the US Clinical Trial of PNEUMOSTEM for Treating Lung Disease is Published in International Journal2019/05/13STEM CELL THERAPEUTIC
MEDIPOST Clears Product Approval Renewal of CARTISTEM by the Ministry of Food and Drug Safety(MFDS)2019/03/26STEM CELL THERAPEUTIC
MEDIPOST, acquires a Japanese patent for the mesenchymal stem cell culture method2019/01/30STEM CELL THERAPEUTIC
MEDIPOST, ends phase I and II clinical trials with PNEUMOSTEM, the effective treatment of BPD for preterm infants2019/01/08STEM CELL THERAPEUTIC
